Sudarshan Pharma (I) Stock Price Analysis and Quick Research Report. Is Sudarshan Pharma (I) an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sudarshan Pharma (I). 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sudarshan Pharma (I) has a PE ratio of 40.8590885280251 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sudarshan Pharma (I) has ROA of 4.634% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sudarshan Pharma (I) has a Current ratio of 1.294.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sudarshan Pharma (I) has a ROE of 13.2802%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Sudarshan Pharma (I) has a Debt to Equity ratio of 1.3566 which means that the company has low proportion of debt in its capital.

• Sales growth: Sudarshan Pharma (I) has reported revenue growth of 7.9354% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Sudarshan Pharma (I) for the current financial year is 7.66212974359537%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sudarshan Pharma (I) is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sudarshan Pharma (I) is Rs 0.9545. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sudarshan Pharma (I) in Ticker for free. Also, one can get the intrinsic value of Sudarshan Pharma (I) by using Valuation Calculators, which are available with a Finology ONE subscription. 

Sudarshan Pharma (I) FAQs

Q1. What is Sudarshan Pharma (I) share price today?
Ans: The current share price of Sudarshan Pharma (I) is Rs 39.

Q2. What is the market capitalisation of Sudarshan Pharma (I)?
Ans: Sudarshan Pharma (I) has a market capitalisation of Rs 992.43534 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Sudarshan Pharma (I)?
Ans: The PE ratio of Sudarshan Pharma (I) is 40.8590885280251 and the P/B ratio of Sudarshan Pharma (I) is 3.04316614126533, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Sudarshan Pharma (I) share?
Ans: The 52-week high share price of Sudarshan Pharma (I) is Rs 42.79, and the 52-week low share price of Sudarshan Pharma (I) is Rs 18.5.

Q5. Does Sudarshan Pharma (I) pay dividends?
Ans: Currently, Sudarshan Pharma (I) does not pay dividends. Dividend yield of Sudarshan Pharma (I) is around 0%.

Q6. What are the face value and book value of Sudarshan Pharma (I) shares?
Ans: The face value of Sudarshan Pharma (I) shares is Rs 1, while the book value per share of Sudarshan Pharma (I) is around Rs 12.8156. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Sudarshan Pharma (I)?
Ans: Sudarshan Pharma (I) has a total debt of Rs 172.9554 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Sudarshan Pharma (I)?
Ans: The ROE of Sudarshan Pharma (I) is 13.2802% and ROCE of Sudarshan Pharma (I) is 14.2503%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Sudarshan Pharma (I) a good buy for the long term?
Ans: The Sudarshan Pharma (I) long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Sudarshan Pharma (I) undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Sudarshan Pharma (I) appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Sudarshan Pharma (I)’s financials?
Ans: You can review Sudarshan Pharma (I)’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.